跳至主要内容
临床试验/NCT01177865
NCT01177865Unknown不适用

Evaluating Patient Preferences for the Treatment of Localized Prostate Cancer - A Discrete Choice Experiment

University College London Hospitals2 个研究点 分布在 1 个国家目标入组 432 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
432
试验地点
2
主要终点
Preferences for, and trade-offs between, the attributes of pre-treatment evaluation with general anaesthetic biopsies and post-treatment frequency of biopsies

研究概览

简要总结

RATIONALE: Gathering information about patients with prostate cancer may help doctors learn more about how patients choose treatment options.

PURPOSE: This study is looking at treatment choice in patients with localized prostate cancer.

详细描述

OBJECTIVES:

Primary

  • To evaluate the importance of prostate cancer treatment characteristics to men with localized prostate cancer.
  • To determine to what extent men will choose the strengths and weaknesses of one treatment over a different set of strengths and weaknesses of another treatment when making a choice between them.

Secondary

  • To determine the correlation between attributes that are important to men and baseline demographics, functional status, and disease risk characteristics.

研究设计

研究类型
Interventional
主要目的
Health Services Research

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • DISEASE CHARACTERISTICS:
  • Histological diagnosis of adenocarcinoma of the prostate on transrectal or transperineal template prostate biopsies
  • Clinical stage ≤ T2c N0 M0 (radiological T3a allowed)
  • Local staging imaging as per guidelines to demonstrate localized disease (e.g., MRI, CT, and/or bone scan)
  • No metastatic disease or nodal disease outside the prostate on bone scan or cross-sectional imaging
  • No prior prostate surgery for cancer control (e.g., radical prostatectomy, high-intensity focused ultrasound ablation, cryosurgery, or photodynamic therapy) or other treatment for prostate cancer
  • Gleason grade ≤ 7
  • Serum PSA ≤ 15 ng/mL
  • PATIENT CHARACTERISTICS:
  • Not specified
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior radiotherapy
  • No androgen suppression/hormone treatment within the previous 12 months for prostate cancer

排除标准

  • 未提供

结局指标

主要结局

Preferences for, and trade-offs between, the attributes of pre-treatment evaluation with general anaesthetic biopsies and post-treatment frequency of biopsies

Treatment choice in respect to risks to sexual function and urinary function, return to normal activities, aim to treat the whole gland or only cancer areas or important cancer areas, retreatment rate, and mortality rate

次要结局

  • Correlation between attributes important to men and baseline demographics, functional status, and disease risk characteristics

研究者

发起方
University College London Hospitals
申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Study of Treatment Choice in Patients With Localized... | 临床试验